Henry F. Chambers

41.8k citations
257 papers · 27.6k indexed · 10 hit papers · h-index 74
Topics
Antimicrobial Resistance in Staphylococcus (170 papers)Bacterial Identification and Susceptibility Testing (92 papers)Antibiotic Resistance in Bacteria (55 papers)

In The Last Decade

Henry F. Chambers

246 papers receiving 26.5k citations

Hit Papers

Clinical Practice Guidelines by the Infectio...19972026200620162011200920142011201010002.0k3.0k

Peers

Henry F. Chambers
Comparison fields: 5 of 176
  • Infectious Diseases 19.0k
  • Clinical Biochemistry 9.2k
  • Molecular Biology 7.3k
  • Public Health, Environmental and Occupational Health 6.9k
  • Epidemiology 6.6k
Replace Barbara E. Murray with:
Barbara E. Murray United States
Vance G. Fowler United States
Michael J. Rybak United States
Arnold S. Bayer United States
Barry N. Kreiswirth United States
Fred C. Tenover United States
Alex van Belkum Netherlands
Daniel J. Diekema United States
Henri A. Verbrugh Netherlands
Mary Jane Ferraro United States
Henry F. Chambers relative to Barbara E. Murray United States Barbara E. Murray's profile →
Citations per field
00.5×1.5×
Barbara E. Murray · 1×
Citations per year

Countries citing papers authored by Henry F. Chambers

Since Specialization
Citations

This map shows the geographic impact of Henry F. Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry F. Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry F. Chambers more than expected).

Fields of papers citing papers by Henry F. Chambers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry F. Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry F. Chambers. The network helps show where Henry F. Chambers may publish in the future.

Co-authorship network of co-authors of Henry F. Chambers

This figure shows the co-authorship network connecting the top 25 collaborators of Henry F. Chambers. A scholar is included among the top collaborators of Henry F. Chambers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry F. Chambers. Henry F. Chambers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 7
3 2
4 0
5 0
6 15
7 0
8 17
9 2
10 35
11 4
12 28
13 19
14 30
15 322
16 74
17 61
18 158
19 121
20 27

About Henry F. Chambers

Henry F. Chambers is a scholar working on Clinical Biochemistry, Applied Microbiology and Biotechnology and Molecular Medicine, having authored 257 papers that have together received 27.6k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (170 papers), Bacterial Identification and Susceptibility Testing (92 papers) and Antibiotic Resistance in Bacteria (55 papers). The work is most often cited by research in Clinical Biochemistry (9.2k citations), Infectious Diseases (19.0k citations) and Applied Microbiology and Biotechnology (1.6k citations). Henry F. Chambers has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Frank R. DeLeo, Sheldon L. Kaplan, Catherine Liu, Arnold S. Bayer, C J Hackbarth, Michaël Otto, James C. Wade, Sherwood L. Gorbach, José G. Montoya and Jan V. Hirschmann. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026